Its revenues increased 6.8% in 2012 to RON412.25 million, and overall expenses climbed 8.1% to RON398.94 million.
Businessman Mihai Miron indirectly owns 35.23% of Ropharma, through Rimia Investments (17.71%) and ADD Pharmaceuticals (17.52%). USA-registered Arrow Pharmaceuticals controls 31.29% of the company’s stock. Private pension fund AZT Viitorul Tau – ALLIANZ owns 5.53% of Ropharma.
On the Bucharest stock market Thursday, Ropharma closed flat on the day at RON0.69 a share. (EUR1=RON4.3698)